Farah Ballout

University of Miami — United States

Medicine · Health Sciences

13h-index719citations81works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(23), Gastrointestinal Tumor Research and Treatment(19), Pancreatic and Hepatic Oncology Research(18), Esophageal Cancer Research and Treatment(14), Ferroptosis and cancer prognosis(9)

Publications81 total

Enhancing the antitumor efficacy using a combination of FGFR4 Inhibitor (H3B-6527) and oxaliplatin in gastric cancer
Neoplasia·2025· 1 citedOpen Access
Correction: Al Bitar et al. Thymoquinone Radiosensitizes Human Colorectal Cancer Cells in 2D and 3D Culture Models. Cancers 2022, 14, 1363
Cancers·2025· 1 citedOpen Access
1111: TARGETING APE1-REDOX FUNCTION REVERSES SOX9-MEDIATED CHEMORESISTANCE IN ESOPHAGEAL ADENOCARCINOMA
Gastroenterology·2025
Su1312: APE1 MEDIATES ANGIOGENESIS BY REGULATING SMAD3 IN ESOPHAGEAL ADENOCARCINOMA
Gastroenterology·2025
Su1308: APE1/NF-κB/PRDX2 ACTIVATED BY REFLUX CONDITIONS MEDIATES CHEMORESISTANCE IN ESOPHAGEAL ADENOCARCINOMA BY SUPPRESSING FERROPTOSIS
Gastroenterology·2025
Abstract 542: Chronic gastroesophageal reflux promotes chemoresistance in esophageal adenocarcinoma through APE1-redox-dependent PRDX2 activation and ferroptosis inhibition
Cancer Research·2025
Abstract 3847: APE1 mediates angiogenesis by stabilizing SMAD3 and blocking its ubiquitin induced degradation in esophageal adenocarcinoma
Cancer Research·2025
Abstract 6968: Targeting overexpressed NEK2 kinase in esophageal adenocarcinoma
Cancer Research·2025
Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors
International Journal of Molecular Sciences·2025· 5 citedOpen Access
Editorial: Modelling esophageal adenocarcinoma
Frontiers in Molecular Biosciences·2025Open Access
ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoids
Pharmacological Reports·2024· 4 cited
Esophageal adenocarcinoma models: a closer look
Frontiers in Molecular Biosciences·2024· 2 citedOpen Access
Supplementary Table S3 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Figure S2 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Figure S3 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Table S2 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Figure S4 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Table S2 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Table S1 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Figure S4 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
page 1 of 5Next →

Frequent Co-authors

Dunfa Peng(23), Heng Lu(21), Zheng Chen(20), Lei Chen(19), Oliver G. McDonald(18), Wassim Abou‐Kheir(16), Wael El‐Rifai(16), Alissar Monzer(14), Hisham F. Bahmad(11), Silvia Giordano(11), Alexander Zaika(11), Hala Gali‐Muhtasib(10), Nadeem S. Bhat(10), Alan S. Livingstone(9), Jianwen Que(8), Steven Chen(8), Xiaodian Sun(8), Simona Corso(8), Deborah Mukherji(7), Wael El-Rifai(7)